Artivion (AORT) Acquisitions (2012 - 2020)

Artivion (AORT) reported Acquisitions of -$524000.0 for Q4 2020, up 99.42% quarter-over-quarter from -$89.9 million in Q4 2016.

Artivion (AORT) Acquisitions (2012 - 2020) Analysis & Trends

Artivion has reported Acquisitions for 3 years, with the latest figure at -$524000.0 in Q4 2020.

For the quarter ending Q4 2020, Acquisitions changed N/A year-over-year to -$524000.0; the trailing twelve-month figure through Dec 2020 stood at -$90.4 million (changed N/A YoY), and the FY2020 full-year result was $59.1 million, changed N/A from the prior year.
Acquisitions for Q4 2020 stood at -$524000.0, up from -$89.9 million in the prior quarter.
The five-year high for Acquisitions was $91.2 million in Q1 2016, with the low at -$89.9 million in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	22.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-268.10 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	2.30 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Artivion	1.02 Bn	961.48 Mn	75.45 Mn	-

Download Data